Insider buying last 90 days
No open-market insider purchases were filed for KMB in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 4 close
Kimberly-Clark's week was shaped by a "Bear of the Day" designation citing disappointing growth, stagnant sales, and new financial challenges tied to the Kenvue acquisition, alongside a separate piece noting the company's 92 consecutive years of dividend payments and 54 consecutive years of dividend increases, supported by net income of $2.5 billion in 2024 and $2.0 billion in 2025. Several insider filings tied to the Kenvue deal also surfaced, reflecting small share allocations to directors and the CEO.
Shares closed at $108.79, up 4.1% on the day, sitting between the 50-day average of $102.61 and the 200-day average of $103.10. The GekkoIndex reads 52.2, placing KMB in the Neutral zone. The stock trades 10.8% below Gekko Fair Value of $121.93.
Kimberly-Clark reports earnings on 5 November, before the open, placing the release inside the next 20-trading-day window; the prior report produced a 4.5% reaction, part of an average absolute move of 3.6% over the last eight quarters, with six beats. Over the past 90 days, Congress recorded one buy and no sales, and one trailblazer holder is listed. Seasonally, the next 20 trading days have averaged +5.4% over five years, rising in five of them. The analyst consensus target stands at $114.62, implying 5.4% upside, across 9 firms with 3 buy, 5 hold and 1 sell ratings.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Kimberly-Clark scores 3 supportive, 2 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed1 headwind
Averages disagree
Close $108.79 sits between the 50-day ($102.61) and 200-day ($103.10) averages, or the averages disagree.
See the chart52.2, Neutral
Reading 52.2 is in the Neutral zone.
See the GekkoIndex10.8% below
Price is 10.8% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: Congress 1 buy / 0 sales.
See smart moneyReports today
Reports on Nov 5, 2026, today — inside a typical 20-trading-day hold.
See earnings+5.4% on average
From this point in the calendar, the next 20 trading days averaged +5.4% over 5 years, rising in 5 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Kimberly-Clark closed at $108.79 on Nov 4, 2026, +6.4% over the past year, inside a 52-week range of $92.42 to $116.82.
Use the left and right arrow keys to read daily values.
Put KMB on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Kimberly-Clark produces personal care and paper-based household goods, sold largely to shoppers in the United States. It is recognized for consumer brands such as Huggies, Pull-Ups, Kotex, Poise, Depend, Kleenex, Scott, Cottonelle and Viva, covering items like diapers, training pants, wipes, feminine and incontinence care, tissue, towels and napkins.
The company is structured around two divisions, one serving North America and another covering international personal care markets, the latter offering similar baby, child, feminine and adult care lines under names including Huggies, Kotex, Goodfeel, Intimus and Depend. Goods meant for home use reach buyers through grocery chains, mass retailers, pharmacies, club stores, department stores, independent distributors and online sales, while items built for workplaces and institutions are supplied to manufacturers, hotels, offices, food service operations and similar large-scale facilities, again including internet-based sales.
Founded in 1872, Kimberly-Clark keeps its headquarters in Dallas, Texas, and its stock trades on the NASDAQ under the ticker KMB.
Kimberly-Clark’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 52.2, in the Neutral zone, up 0.7 points over five sessions.
Up 0.7 points over five sessions.
Reading for Nov 4, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 48 | +0.6% | +2.6% | ||
| Accumulation | 283 | +0.1% | −0.1% | ||
| Neutral (current zone) | 326 | −0.2% | −0.7% | ||
| Distribution | 38 | −0.2% | −1.2% | ||
| Selling | 2 | Too few readings yet | |||
Average KMB share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Kimberly-Clark trades 10.8% below Gekko Fair Value of $121.93, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Kimberly-Clark shares are worth, recalculated every trading day.
$121.93
Gekko Fair Value, Nov 4, 2026
10.8% Undervalued
At the end of Aug 2026 the price was 16.2% below the estimate.
No open-market insider purchases were filed for Kimberly-Clark, and members of Congress disclosed 1 purchase and 0 sales, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for KMB in the last 90 days.
From Form 4 filings, dated to when each was filed.
1trade disclosed: 1 purchase and 0 sales.
| Member | Amount | Disclosed |
|---|---|---|
| Ro Khanna House, CA, purchase | $1,001 - $15,000 | Oct 9 traded Sep 4 |
From congressional disclosures, which report amounts as ranges.
Kimberly-Clark has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds KMB.
Kimberly-Clark reports on Nov 5, 2026, before the open (today), and beat the EPS estimate in 6 of its last 8 reports.
Nov 5, 2026
Expected before the open, today
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 4, 2026 | $1.80 est $2.01 | $4.19B est $4.22B | +4.5% |
| Apr 28, 2026 | $1.97 est $1.93 | $4.16B est $4.09B | −2.2% |
| Jan 27, 2026 | $1.86 est $1.81 | $4.08B est $4.09B | −1.6% |
| Oct 30, 2025 | $1.82 est $1.75 | $4.13B est $4.09B | +2.6% |
| Aug 1, 2025 | $1.92 est $1.67 | $4.16B est $4.85B | +6.8% |
| Apr 22, 2025 | $1.93 est $1.89 | $4.84B est $4.89B | −4.8% |
| Jan 28, 2025 | $1.50 est $1.51 | $4.93B est $4.86B | −1.3% |
| Oct 22, 2024 | $1.83 est $1.71 | $4.95B est $5.06B | −5.1% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Kimberly-Clark is $114.62, +5.4% from the last close, from 9 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 9 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 28 | UBS | $113 | +3.9% |
| Oct 23 | Canaccord Genuity | $105 | −3.5% |
| Oct 20 | Bank of America Securities | $120 | +10.3% |
| Oct 19 | Bank of America Securities | $120 | +10.3% |
| Oct 16 | Wells Fargo | $100 | −8.1% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 4, Kimberly-Clark averaged +5.4% across the last 5 years, rising in 5 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.9% | 4 of 5 |
| Next 10 trading days | +2.9% | 5 of 5 |
| Next 15 trading days | +4.8% | 5 of 5 |
| Next 20 trading days | +5.4% | 5 of 5 |
| Next 30 trading days | +3.7% | 4 of 5 |
For scale, KMB’s typical 20-trading-day move in either direction is about 4%.
Kimberly-Clark’s market cap is $36.18B, with a P/E ratio of 21.4 and revenue of $16.58B over the last twelve months.
Coverage of Kimberly-Clark this week reads neutral: 6 positive, 13 neutral and 1 negative headlines.
Kimberly-Clark’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| PGProcter & Gamble | Neutral | 11.0% below |
| CLColgate-Palmolive | Neutral | 11.8% below |
| ELEstee Lauder Companies | Neutral | 17.4% above |
| KVUEKenvue | Neutral | 15.5% below |
| CHDChurch & Dwight | Neutral | 4.6% above |
| CLXClorox | Distribution | 37.3% below |
A peer links to its own page where one exists.
Kimberly-Clark’s market cap is $36.18B at the Nov 4, 2026 close of $108.79, with 332.6M shares outstanding. The shares trade on a P/E ratio of 21.4.
The consensus analyst 12-month price target for Kimberly-Clark is $114.62, +5.4% from the last close. Of the 9 firms that rated the stock in the last 90 days, 3 rate it a buy, 5 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Kimberly-Clark is undervalued: the Nov 4, 2026 close of $108.79 is 10.8% below Gekko Fair Value of $121.93. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Kimberly-Clark is expected to report on Nov 5, 2026, before the market opens (today). Analysts expect earnings of $1.65 per share on revenue of $4.13B. Kimberly-Clark beat the earnings estimate in 6 of its last 8 reports, moving 3.6% on average across the report.
Kimberly-Clark’s 52-week high is $116.82 and its 52-week low is $92.42; it closed at $108.79 on Nov 4, 2026, +6.4% over the past year. Over the last five years the shares peaked at $150.45 on Mar 10, 2025.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 6 items with data read as supportive (fair value, smart money and seasonality), 2 as mixed (trend and gekkoindex) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.